69 related articles for article (PubMed ID: 2666224)
1. [Evaluation of beta cell function in non-insulin-dependent diabetes mellitus (NIDDM) and its correlations with clinico-metabolic parameters].
Santoro E; Gianni R; Maggi L; Tomassini CR; Bisacchi U
G Clin Med; 1989 Feb; 70(2):95-9. PubMed ID: 2666224
[TBL] [Abstract][Full Text] [Related]
2. [Clinical usefulness of the glucagon test in the study of pancreatic islet cell function].
Llorente I; Goñi MJ; Forga L; Monreal M; Lizcano F; Moncada E
Rev Med Univ Navarra; 1992; 37(1):25-9. PubMed ID: 1626165
[TBL] [Abstract][Full Text] [Related]
3. The role of diminished beta cell reserve and insulin resistance in secondary sulfonylurea failure of type 2 diabetes mellitus.
Rattarasarn C; Thamprasit A; Leelawattana R; Soonthornpun S; Setasuban W
J Med Assoc Thai; 2001 Dec; 84(12):1754-62. PubMed ID: 11999824
[TBL] [Abstract][Full Text] [Related]
4. C-peptide response to glucagon in type 2 diabetes mellitus: a comparison with oral glucose tolerance test.
Iwasaki Y; Kondo K; Hasegawa H; Oiso Y
Diabetes Res; 1994; 25(3):129-37. PubMed ID: 7671552
[TBL] [Abstract][Full Text] [Related]
5. Estimation of B-cell function by the urinary excretion rate of C-peptide in diabetic patients: comparison with C-peptide response to glucagon and to a mixed meal.
Pasquali R; Buratti P; Biso P; Patrono D; Capelli M; Pasqui F; Melchionda N
Diabete Metab; 1987 Feb; 13(1):44-51. PubMed ID: 3552774
[TBL] [Abstract][Full Text] [Related]
6. Pancreatic beta cell response in insulin treated NIDDM patients limitations of a random C-peptide measurement.
Snehalatha C; Ramachandran A; Mohan V; Viswanathan M
Diabete Metab; 1987 Feb; 13(1):27-30. PubMed ID: 3552773
[TBL] [Abstract][Full Text] [Related]
7. C-peptide response to glucagon in diabetics with and without complications.
Smith RB; Pyke DA; Watkins PJ; Binder C; Faber OK
N Z Med J; 1979 Apr; 89(634):304-6. PubMed ID: 377156
[TBL] [Abstract][Full Text] [Related]
8. Residual B-cell function in insulin dependent (Type 1) and non insulin-dependent (Type 2) diabetics (relationship between 24-hour C-peptide excretion and the clinical features of diabetes).
Gerö L; Korányi L; Tamás G
Diabete Metab; 1983 Sep; 9(3):183-7. PubMed ID: 6360742
[TBL] [Abstract][Full Text] [Related]
9. [Glutamic acid decarboxylase autoantibodies (antiGAD-Ab) in patients with non-insulin dependent diabetes mellitus (NIDDM)].
Martinka E; Straková J; Ocenásová A; Pullmannová D; Petrisková J; Mácková N; Sutarík L; Galajda P; Baláz D; Kerný J; Vladár L; Mokán M
Vnitr Lek; 1998 Jan; 44(1):17-22. PubMed ID: 9750478
[TBL] [Abstract][Full Text] [Related]
10. Beta cell response to oral glimepiride administration during and following a hyperglycaemic clamp in NIDDM patients.
van der Wal PS; Draeger KE; van Iperen AM; Martini C; Aarsen M; Heine RJ
Diabet Med; 1997 Jul; 14(7):556-63. PubMed ID: 9223393
[TBL] [Abstract][Full Text] [Related]
11. The beta-cell response to glucagon and mixed meal stimulation in non-insulin dependent diabetes.
Gjessing HJ; Damsgaard EM; Matzen LE; Faber OK; Frøland A
Scand J Clin Lab Invest; 1988 Dec; 48(8):771-7. PubMed ID: 3070718
[TBL] [Abstract][Full Text] [Related]
12. [Clinical significance of measuring serum c-peptide before and after glucagon injection].
Kan Y; Chi Z
Zhonghua Yi Xue Za Zhi; 1991 Jan; 71(1):16-7, 4. PubMed ID: 1850647
[TBL] [Abstract][Full Text] [Related]
13. Reproducibility of beta-cell function estimates in non-insulin-dependent diabetes mellitus.
Gjessing HJ; Damsgaard EM; Matzen LE; Frøland A; Faber OK
Diabetes Care; 1987; 10(5):558-62. PubMed ID: 3315512
[TBL] [Abstract][Full Text] [Related]
14. Progressive deterioration of beta-cell function in nonobese type 2 diabetic subjects. Postprandial plasma C-peptide level is an indication of insulin dependency.
Prando R; Odetti P; Melga P; Giusti R; Ciuchi E; Cheli V
Diabetes Metab; 1996 Jun; 22(3):185-91. PubMed ID: 8697306
[TBL] [Abstract][Full Text] [Related]
15. Residual B cell function in patients with long-standing NIDDM and its relation to metabolic control and diabetic complications.
Iwase M; Kikuchi M; Nunoi K; Maki Y; Wakisaka M; Wada M; Fujishima M
Endocrinol Jpn; 1988 Dec; 35(6):803-8. PubMed ID: 3074917
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic B-cell function in non-insulin-dependent diabetes mellitus during successive periods of sulfonylurea and insulin treatment: serum C-peptide response to glucagon and urine C-peptide excretion.
Hsieh SD; Iwamoto Y; Matsuda A; Kuzuya T
Endocrinol Jpn; 1987 Aug; 34(4):561-7. PubMed ID: 3315640
[TBL] [Abstract][Full Text] [Related]
17. The C-peptide response to glucagon injections in IDDM and NIDDM patients.
Poulsen S; Billesbølle P; Kølendorf K; Thorsteinsson B
Horm Metab Res; 1985 Jan; 17(1):39-40. PubMed ID: 3967844
[No Abstract] [Full Text] [Related]
18. C-peptide response to glucagon in young diabetics.
Juang JH; Huang BY; Huang HS; Lin JD; Huang MJ
Taiwan Yi Xue Hui Za Zhi; 1989 Jun; 88(6):579-83. PubMed ID: 2677232
[TBL] [Abstract][Full Text] [Related]
19. [Plasma C-peptide assay and the clinical significance].
Kaku K; Nagasaka Y; Kaneko T
Nihon Rinsho; 1990 Feb; 48 Suppl():48-50. PubMed ID: 2192142
[No Abstract] [Full Text] [Related]
20. Abnormal glucose modulation of islet A- and B-cell responses to arginine in non-insulin-dependent diabetes mellitus.
Dimitriadis GD; Pehling GB; Gerich JE
Diabetes; 1985 Jun; 34(6):541-7. PubMed ID: 3891467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
